Logo image of ALEUA.PA

EURASIA GROUPE (ALEUA.PA) Stock Fundamental Analysis

EPA:ALEUA - Euronext Paris - Matif - FR0010844001 - Common Stock - Currency: EUR

1.22  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALEUA. ALEUA was compared to 70 industry peers in the Real Estate Management & Development industry. ALEUA has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALEUA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALEUA had positive earnings in the past year.
In the past year ALEUA has reported a negative cash flow from operations.
In the past 5 years ALEUA has always been profitable.
In multiple years ALEUA reported negative operating cash flow during the last 5 years.
ALEUA.PA Yearly Net Income VS EBIT VS OCF VS FCFALEUA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.56%, ALEUA belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
ALEUA has a better Return On Equity (11.95%) than 91.43% of its industry peers.
ALEUA's Return On Invested Capital of 1.08% is in line compared to the rest of the industry. ALEUA outperforms 58.57% of its industry peers.
Industry RankSector Rank
ROA 5.56%
ROE 11.95%
ROIC 1.08%
ROA(3y)2.84%
ROA(5y)2.89%
ROE(3y)5.73%
ROE(5y)6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ALEUA.PA Yearly ROA, ROE, ROICALEUA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10

1.3 Margins

ALEUA's Profit Margin of 73.63% is amongst the best of the industry. ALEUA outperforms 92.86% of its industry peers.
In the last couple of years the Profit Margin of ALEUA has declined.
The Operating Margin of ALEUA (15.45%) is better than 65.71% of its industry peers.
The Gross Margin of ALEUA (91.16%) is better than 90.00% of its industry peers.
ALEUA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.45%
PM (TTM) 73.63%
GM 91.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.28%
PM growth 5YN/A
GM growth 3Y10.38%
GM growth 5Y1.44%
ALEUA.PA Yearly Profit, Operating, Gross MarginsALEUA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

ALEUA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALEUA remains at a similar level compared to 1 year ago.
ALEUA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALEUA is higher compared to a year ago.
ALEUA.PA Yearly Shares OutstandingALEUA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALEUA.PA Yearly Total Debt VS Total AssetsALEUA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ALEUA has an Altman-Z score of 0.59. This is a bad value and indicates that ALEUA is not financially healthy and even has some risk of bankruptcy.
ALEUA has a Altman-Z score (0.59) which is in line with its industry peers.
A Debt/Equity ratio of 0.27 indicates that ALEUA is not too dependend on debt financing.
ALEUA's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. ALEUA outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACC0.24
WACC4.51%
ALEUA.PA Yearly LT Debt VS Equity VS FCFALEUA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

ALEUA has a Current Ratio of 0.37. This is a bad value and indicates that ALEUA is not financially healthy enough and could expect problems in meeting its short term obligations.
ALEUA has a worse Current ratio (0.37) than 71.43% of its industry peers.
A Quick Ratio of 0.22 indicates that ALEUA may have some problems paying its short term obligations.
The Quick ratio of ALEUA (0.22) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.22
ALEUA.PA Yearly Current Assets VS Current LiabilitesALEUA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.10% over the past year.
Measured over the past years, ALEUA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -27.96% on average per year.
ALEUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.66%.
The Revenue for ALEUA have been decreasing by -11.92% on average. This is quite bad
EPS 1Y (TTM)63.1%
EPS 3Y-27.96%
EPS 5YN/A
EPS Q2Q%30.43%
Revenue 1Y (TTM)-29.66%
Revenue growth 3Y-20.5%
Revenue growth 5Y-11.92%
Sales Q2Q%-44.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEUA.PA Yearly Revenue VS EstimatesALEUA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.40, which indicates a rather cheap valuation of ALEUA.
ALEUA's Price/Earnings ratio is rather cheap when compared to the industry. ALEUA is cheaper than 97.14% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALEUA to the average of the S&P500 Index (24.85), we can say ALEUA is valued rather cheaply.
Industry RankSector Rank
PE 0.4
Fwd PE N/A
ALEUA.PA Price Earnings VS Forward Price EarningsALEUA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALEUA is valued cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.89
ALEUA.PA Per share dataALEUA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The decent profitability rating of ALEUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALEUA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EURASIA GROUPE

EPA:ALEUA (5/7/2025, 7:00:00 PM)

1.22

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.97%
Ins Owner ChangeN/A
Market Cap9.21M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.4
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.06
EV/EBITDA 13.89
EPS(TTM)3.05
EY250%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.68
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS4.27
BVpS26.31
TBVpS22.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.56%
ROE 11.95%
ROCE 1.47%
ROIC 1.08%
ROICexc 1.08%
ROICexgc 1.2%
OM 15.45%
PM (TTM) 73.63%
GM 91.16%
FCFM N/A
ROA(3y)2.84%
ROA(5y)2.89%
ROE(3y)5.73%
ROE(5y)6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.28%
PM growth 5YN/A
GM growth 3Y10.38%
GM growth 5Y1.44%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA 6.67
Cap/Depr 99.8%
Cap/Sales 9.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.22
Altman-Z 0.59
F-Score5
WACC4.51%
ROIC/WACC0.24
Cap/Depr(3y)655.18%
Cap/Depr(5y)422.85%
Cap/Sales(3y)15.94%
Cap/Sales(5y)13.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.1%
EPS 3Y-27.96%
EPS 5YN/A
EPS Q2Q%30.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.66%
Revenue growth 3Y-20.5%
Revenue growth 5Y-11.92%
Sales Q2Q%-44.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y114.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.41%
OCF growth 3YN/A
OCF growth 5YN/A